Gonadotropin-releasing hormone in apoptosis of prostate cancer cells

Cancer Letters

Volumn 234, Issue 2, 2006, Pages 109-123

  Kraus, Sarah ^a   Naor, Zvi ^b   Seger, Rony ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

GnRH a; Gonadotropin; MAPK; PKB; Prostate cancer cells; Signaling cascades

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIANDROGEN; BUSERELIN; CETRORELIX; GONADORELIN; GONADORELIN ANTAGONIST; GONADORELIN RECEPTOR; GONADORELIN[1 [N ACETYL 3 (2 NAPHTHYL) DEXTRO ALANINE] 2 (4 CHLORO DEXTRO PHENYLALANINE) 3 DEXTRO TRYPTOPHAN 6 DEXTRO CITRULLINE 10 DEXTRO ALANINE]; GONADORELIN[1 [N ACETYL 3 (2 NAPHTHYL) DEXTRO ALANINE] 2 (4 CHLORO DEXTRO PHENYLALANINE) 3 DEXTRO TRYPTOPHAN 6 DEXTRO HOMOCITRULLINE 10 DEXTRO ALANINE]; GONADORELIN[1,3 (N ACETYL DEXTRO TRYPTOPHAN) 2 (4 CHLORO DEXTRO PHENYLALANINE) 6 DEXTRO LYSINE 10 DEXTRO ALANINE]; GOSERELIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CAUSE OF DEATH; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM CANCER; GENE MUTATION; HORMONE ACTION; HORMONE DEPENDENCE; HUMAN; LEIOMYOMA; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; UTERUS CANCER;

EID: 33644992893     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.02.038     Document Type: Review

References (134)

1. J.D. Neill, L.C. Musgrove, and L.W. Duck Newly recognized GnRH receptors: function and relative role Trends Endocrinol. Metab. 15 2004 383 392
2. F. Ruf, and S.C. Sealfon Genomics view of gonadotrope signaling circuits Trends Endocrinol. Metab. 15 2004 331 338
3. R.P. Millar, Z.L. Lu, A.J. Pawson, C.A. Flanagan, K. Morgan, and S.R. Maudsley Gonadotropin-releasing hormone receptors Endocr. Rev. 25 2004 235 275
4. C.K. Cheng, and P.C. Leung Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II and their receptors in humans Endocr. Rev. 2004
5. G. Fink Gonadotropin secretion and its control E. Knobil J.D. Neill The Physiology of Reproduction 1988 Raven Press New York, NY 1349 1377
6. P.M. Conn, and W.F. Crowley Jr. Gonadotropin-releasing hormone and its analogs Annu. Rev. Med. 45 1994 391 405
7. R.F. Casper Clinical uses of gonadotropin-releasing hormone analogues Can. Med. Assoc. J. 144 1991 153 158
8. G. Emons, and A.V. Schally The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers Hum. Reprod. 9 1994 1364 1379
9. M. Filicori Gonadotrophin-releasing hormone agonists. A guide to use and selection Drugs 48 1994 41 58
10. H. Miyamoto, E.M. Messing, and C. Chang Androgen deprivation therapy for prostate cancer: current status and future prospects Prostate 61 2004 332 353
11. T. Segal-Abramson, H. Kitroser, J. Levy, A.V. Schally, and Y. Sharoni Direct effects of luteinizing hormone-releasing hormone agonists and antagonists on MCF-7 mammary cancer cells Proc. Natl Acad. Sci. USA 89 1992 2336 2339
12. M.L. Kottler, A. Starzec, M.C. Carre, J.P. Lagarde, A. Martin, and R. Counis The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer Int. J. Cancer 71 1997 595 599
13. G. Emons, O. Ortmann, M. Becker, G. Irmer, B. Springer, and R. Laun High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines Cancer Res. 53 1993 5439 5446
14. G. Srkalovic, J.L. Wittliff, and A.V. Schally Detection and partial characterization of receptors for [D-Trp6]-luteinizing hormone-releasing hormone and epidermal growth factor in human endometrial carcinoma Cancer Res. 50 1990 1841 1846
15. E. Chatzaki, C.M. Bax, K.A. Eidne, L. Anderson, J.G. Grudzinskas, and C.J. Gallagher The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor Cancer Res. 56 1996 2059 2065
16. J.Y. Bahk, J.S. Hyun, H. Lee, M.O. Kim, G.J. Cho, B.H. Lee, and W.S. Choi Expression of gonadotropin-releasing hormone (GnRH) and GnRH receptor mRNA in prostate cancer cells and effect of GnRH on the proliferation of prostate cancer cells Urol Res. 26 1998 259 264
17. P. Limonta, R.M. Moretti, M.M. Marelli, D. Dondi, M. Parenti, and M. Motta The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway Endocrinology 140 1999 5250 5256
18. A. Tieva, P. Stattin, P. Wikstrom, A. Bergh, and J.E. Damber Gonadotropin-releasing hormone receptor expression in the human prostate Prostate 47 2001 276 284
19. C. Grundker, P. Volker, K.D. Schulz, and G. Emons Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers Gynecol. Oncol. 78 2000 194 202
20. M.M. Marelli, R.M. Moretti, D. Dondi, M. Motta, and P. Limonta Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells Endocrinology 140 1999 329 334
21. G. Emons, S. Weiss, O. Ortmann, C. Grundker, and K.D. Schulz LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer Eur. J. Endocrinol. 142 2000 665 670
22. P. Limonta, R.M. Montagnani Marelli, and R.M. Moretti LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action Expert Opin. Investig. Drugs 10 2001 709 720
23. S. Kraus, G. Levy, T. Hanoch, Z. Naor, and R.M. Seger Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways Cancer Res. 64 2004 5736 5744
24. S. Maudsley, L. Davidson, A.J. Pawson, R. Chan, R.L. de Maturana, and R.P. Millar Gonadotropin-releasing hormone (GnRH) antagonists promote proapoptotic signaling in peripheral reproductive tumor cells by activating a Galphai-coupling state of the type I GnRH receptor Cancer Res. 64 2004 7533 7544
25. L.E. Miles, A.C. Hanyaloglu, J.R. Dromey, K.D. Pfleger, and K.A. Eidne Gonadotropin-releasing hormone receptor-mediated growth suppression of immortalized LbetaT2 gonadotrope and stable HEK293 cell lines Endocrinology 145 2004 194 204
26. A.V. Schally, A. Arimura, A.J. Kastin, H. Matsuo, Y. Baba, and T.W. Redding Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones Science 173 1971 1036 1038
27. E.A. Dubois, M.A. Zandbergen, J. Peute, and H.J. Goos Evolutionary development of three gonadotropin-releasing hormone (GnRH) systems in vertebrates Brain Res. Bull. 57 2002 413 418
28. S.C. Sealfon, H. Weinstein, and R.P. Millar Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor Endocr. Rev. 18 1997 180 205
29. B. Troskie, N. Illing, E. Rumbak, Y.M. Sun, J. Hapgood, and S. Sealfon Identification of three putative GnRH receptor subtypes in vertebrates Gen. Comp. Endocrinol. 112 1998 296 302
30. J. Reinhart, L.M. Mertz, and K.J. Catt Molecular cloning and expression of cDNA encoding the murine gonadotropin-releasing hormone receptor J. Biol. Chem. 267 1992 21281 21284
31. M. Tsutsumi, W. Zhou, R.P. Millar, P.L. Mellon, J.L. Roberts, and C.A. Flanagan Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor Mol. Endocrinol. 6 1992 1163 1169
32. J.D. Neill, L.W. Duck, J.C. Sellers, and L.C. Musgrove A gonadotropin-releasing hormone (GnRH) receptor specific for GnRH II in primates Biochem. Biophys. Res. Commun. 282 2001 1012 1018
33. B. Faurholm, R.P. Millar, and A.A. Katz The genes encoding the type II gonadotropin-releasing hormone receptor and the ribonucleoprotein RBM8A in humans overlap in two genomic loci Genomics 78 2001 15 18
34. R.P. Millar GnRH II and type II GnRH receptors Trends Endocrinol. Metab. 14 2003 35 43
35. L. Wang, J. Bogerd, H.S. Choi, J.Y. Seong, J.M. Soh, and S.Y. Chun Three distinct types of GnRH receptor characterized in the bullfrog Proc. Natl Acad. Sci. USA 98 2001 361 366
36. Z. Naor Signal transduction mechanisms of Ca2+mobilizing hormones: the case of gonadotropin-releasing hormone Endocr. Rev. 11 1990 326 353
37. S.S. Stojilkovic, M. Tomic, M. Kukuljan, and K.J. Catt Control of calcium spiking frequency in pituitary gonadotrophs by a single-pool cytoplasmic oscillator Mol. Pharmacol. 45 1994 1013 1021
38. B. Poulin, N. Rich, J.L. Mas, C. Kordon, A. Enjalbert, and S.V. Drouva GnRH signalling pathways and GnRH-induced homologous desensitization in a gonadotrope cell line (alphaT3-1) Mol. Cell. Endocrinol. 142 1998 99 117
39. S. Shacham, D. Harris, H. Ben-Shlomo, I. Cohen, D. Bonfil, and F. Przedecki Mechanism of GnRH receptor signaling on gonadotropin release and gene expression in pituitary gonadotrophs Vitam. Horm. 63 2001 63 90
40. Z. Naor, O. Benard, and R. Seger Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor Trends Endocrinol. Metab. 11 2000 91 99
41. C.A. McArdle, J. Franklin, L. Green, and J.N. Hislop Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors J. Endocrinol. 173 2002 1 11
42. S. Kraus, Z. Naor, and R. Seger Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor Arch. Med. Res. 32 2001 499 509
43. D. Harris, D. Chuderland, D. Bonfil, S. Kraus, R. Seger, and Z. Naor Extracellular signal-regulated kinase and c-Src, but not Jun N-terminal kinase, are involved in basal and gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone alpha-subunit promoter Endocrinology 144 2003 612 622
44. M.S. Roberson, A. Misra-Press, M.E. Laurance, P.J. Stork, and R.A. Maurer A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone Mol. Cell. Biol. 15 1995 3531 3539
45. D. Harris, D. Bonfil, D. Chuderland, S. Kraus, R. Seger, and Z. Naor Activation of MAPK cascades by GnRH: ERK and Jun N-terminal kinase are involved in basal and GnRH-stimulated activity of the glycoprotein hormone LHbeta-subunit promoter Endocrinology 143 2002 1018 1025
46. D. Bonfil, D. Chuderland, S. Kraus, D. Shahbazian, I. Friedberg, R. Seger, and Z. Naor Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter Endocrinology 145 2004 2228 2244
47. X. Lin, and P.M. Conn Transcriptional activation of gonadotropin- releasing hormone (GnRH) receptor gene by GnRH: involvement of multiple signal transduction pathways Endocrinology 140 1999 358 364
48. C. Grundker, and G. Emons Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer Reprod. Biol. Endocrinol. 1 2003 65
49. B.H. Shah, and K.J. Catt Matrix metalloproteinases in reproductive endocrinology Trends Endocrinol. Metab. 15 2004 47 49
50. O. Benard, Z. Naor, and R. Seger Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone J. Biol. Chem. 276 2001 4554 4563
51. N.L. Levi, T. Hanoch, O. Benard, M. Rozenblat, D. Harris, and N. Reiss Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42 Mol. Endocrinol. 12 1998 815 824
52. M.S. Roberson, T. Zhang, H.L. Li, and J.M. Mulvaney Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone Endocrinology 140 1999 1310 1318
53. K.L. Pierce, L.M. Luttrell, and R.J. Lefkowitz New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades Oncogene 20 2001 1532 1539
54. S. Kraus, O. Benard, Z. Naor, and R. Seger c-Src is activated by the epidermal growth factor receptor in a pathway that mediates JNK and ERK activation by gonadotropin-releasing hormone in COS7 cells J. Biol. Chem. 278 2003 32618 32630
55. B.H. Shah, M.P. Farshori, and K.J. Catt Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor J. Biol. Chem. 279 2004 414 420
56. D. Stanislaus, S. Ponder, T.H. Ji, and P.M. Conn Gonadotropin-releasing hormone receptor couples to multiple G proteins in rat gonadotrophs and in GGH3 cells: evidence from palmitoylation and overexpression of G proteins Biol. Reprod. 59 1998 579 586
57. B.E. Hawes, S. Barnes, and P.M. Conn Cholera toxin and pertussis toxin provoke differential effects on luteinizing hormone release, inositol phosphate production, and gonadotropin-releasing hormone (GnRH) receptor binding in the gonadotrope: evidence for multiple guanyl nucleotide binding proteins in GnRH action Endocrinology 132 1993 2124 2130
58. C. Grundker, P. Volker, and G. Emons Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase Endocrinology 142 2001 2369 2380
59. A. Imai, H. Takagi, S. Horibe, T. Fuseya, and T. Tamaya Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors J. Clin. Endocrinol. Metab. 81 1996 3249 3253
60. A. Imai, S. Horibe, A. Takagi, and T. Tamaya Gi protein activation of gonadotropin-releasing hormone-mediated protein dephosphorylation in human endometrial carcinoma Am. J. Obstet. Gynecol. 176 1997 371 376
61. H.M. Everest, J.N. Hislop, T. Harding, J.B. Uney, A. Flynn, R.P. Millar, and C.A. McArdle Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus Endocrinology 142 2001 4663 4672
62. A. Lania, G. Mantovani, E. Ferrante, L.M. Zavanone, M. Locatelli, and S. Corbetta Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas J. Endocrinol. Invest. 27 2004 328 333
63. L.Z. Krsmanovic, N. Mores, C.E. Navarro, K.K. Arora, and K.J. Catt An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion Proc. Natl Acad. Sci. USA 100 2003 2969 2974
64. F. Liu, I. Usui, L.G. Evans, D.A. Austin, P.L. Mellon, J.M. Olefsky, and N.J. Webster Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells J. Biol. Chem. 277 2002 32099 32108
65. H. Biebermann, T. Schoneberg, A. Schulz, G. Krause, A. Gruters, G. Schultz, and T. Gudermann A conserved tyrosine residue (Y601) in transmembrane domain 5 of the human thyrotropin receptor serves as a molecular switch to determine G-protein coupling Fed. Am. Soc. Exp. Biol. J. 12 1998 1461 1471
66. W.F. Schwindinger, J. Fredericks, L. Watkins, H. Robinson, J.M. Bathon, and M. Pines Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTP-gamma-azidoanilide photoaffinity labeling Endocrine 8 1998 201 209
67. R. Grosse, S. Roelle, A. Herrlich, J. Hohn, and T. Gudermann Epidermal growth factor receptor tyrosine kinase mediates Ras activation by gonadotropin-releasing hormone J. Biol. Chem. 275 2000 12251 12260
68. R.T. Greenlee, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 2000, CA Cancer J. Clin. 50 2000 7 33
69. S.R. Denmeade, and J.T. Isaacs Development of prostate cancer treatment: the good news Prostate 58 2004 211 224
70. F. Labrie, L. Cusan, J. Gomez, V. Luu-The, B. Candas, A. Belanger, and C. Labrie Major impact of hormonal therapy in localized prostate cancer-death can already be an exception J. Steroid Biochem. Mol. Biol. 92 2004 327 344
71. H. Goethuys, L. Baert, H. Van Poppel, G. Lieskovsky, L.W. Brady, and Z. Petrovich Treatment of metastatic carcinoma of the prostate Am. J. Clin. Oncol. 20 1997 40 45
72. H.L. Lau, X.M. Zhu, P.C. Leung, L.W. Chan, G.F. Chen, and P.S. Chan Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates Int. J. Oncol. 19 2001 1193 1201
73. S.S. Kakar, K. Grantham, L.C. Musgrove, D. Devor, J.C. Sellers, and J.D. Neill Rat gonadotropin-releasing hormone (GnRH) receptor: tissue expression and hormonal regulation of its mRNA Mol. Cell. Endocrinol. 101 1994 151 157
74. L. Ravenna, L. Salvatori, S. Morrone, C. Lubrano, M.R. Cardillo, and F. Sciarra Effects of triptorelin, a gonadotropin-releasing hormone agonist, on the human prostatic cell lines PC3 and LNCaP J. Androl. 21 2000 549 557
75. P. Limonta, D. Dondi, R.M. Moretti, R. Maggi, and M. Motta Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP J. Clin. Endocrinol. Metab. 75 1992 207 212
76. J. Pinski, H. Reile, G. Halmos, K. Groot, and A.V. Schally Inhibitory effects of analogs of luteinizing hormone-releasing hormone on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer Int. J. Cancer 59 1994 51 55
77. B. Szende, G. Srkalovic, K. Groot, K. Lapis, and A.V. Schally Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists Cancer Res. 50 1990 3716 3721
78. D. Dondi, R.M. Moretti, M.M. Marelli, M. Motta, and P. Limonta Growth factors in steroid-responsive prostatic tumor cells Steroids 61 1996 222 225
79. M. Motta, D. Dondi, R.M. Moretti, M. Montagnani Marelli, F. Pimpinelli, R. Maggi, and P. Limonta Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth J. Steroid Biochem. Mol. Biol. 56 1996 107 111
80. D. Dondi, R.M. Moretti, M. Montagnani Marelli, G. Pratesi, D. Polizzi, and M. Milani Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice Int. J. Cancer 76 1998 506 511
81. D.L. Vaux, and S.J. Korsmeyer Cell death in development Cell 96 1999 245 254
82. S.J. Riedl, and Y. Shi Molecular mechanisms of caspase regulation during apoptosis Nat. Rev. Mol. Cell. Biol. 5 2004 897 907
83. A. Thorburn Death receptor-induced cell killing Cell Signal 16 2004 139 144
84. X. Jiang, and X. Wang Cytochrome C-mediated apoptosis Annu. Rev. Biochem. 73 2004 87 106
85. K. Maundrell, B. Antonsson, E. Magnenat, M. Camps, M. Muda, and C. Chabert Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress- activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1 J. Biol. Chem. 272 1997 25238 25242
86. K. Yamamoto, H. Ichijo, and S.J. Korsmeyer BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M Mol. Cell. Biol. 19 1999 8469 8478
87. Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu A JNK-dependent pathway is required for TNFalpha-induced apoptosis Cell 115 2003 61 70
88. A. Lin Activation of the JNK signaling pathway: breaking the brake on apoptosis Bioessays 25 2003 17 24
89. J.A. Hamilton, L.M. Stewart, L. Ajayi, I.C. Gray, N.E. Gray, and K.G. Roberts The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers Br. J. Cancer 82 2000 1671 1676
90. R.J. Vlietstra, D.C. van Alewijk, K.G. Hermans, G.J. van Steenbrugge, and J. Trapman Frequent inactivation of PTEN in prostate cancer cell lines and xenografts Cancer Res. 58 1998 2720 2723
91. C.P. Paweletz, L. Charboneau, V.E. Bichsel, N.L. Simone, T. Chen, and J.W. Gillespie Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front Oncogene 20 2001 1981 1989
92. S.N. Malik, M. Brattain, P.M. Ghosh, D.A. Troyer, T. Prihoda, R. Bedolla, and J.I. Kreisberg Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer Clin. Cancer Res. 8 2002 1168 1171
93. J.I. Kreisberg, S.N. Malik, T.J. Prihoda, R.G. Bedolla, D.A. Troyer, S. Kreisberg, and P.M. Ghosh Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer Cancer Res. 64 2004 5232 5236
94. J. Lin, R.M. Adam, E. Santiestevan, and M.R. Freeman The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells Cancer Res. 59 1999 2891 2897
95. J.R. Graff, B.W. Konicek, A.M. McNulty, Z. Wang, K. Houck, and S. Allen Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression J. Biol. Chem. 275 2000 24500 24505
96. M.M. Hill, and B.A. Hemmings Inhibition of protein kinase B/Akt. implications for cancer therapy Pharmacol. Ther. 93 2002 243 251
97. J.P. Carson, G. Kulik, and M.J. Weber Antiapoptotic signaling in LNCaP prostate cancer cells: a survival signaling pathway independent of phosphatidylinositol 3′-kinase and Akt/protein kinase B Cancer Res. 59 1999 1449 1453
98. Y. Tanaka, M.V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M.G. Kazanietz Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway J. Biol. Chem. 278 2003 33753 33762
99. J.L. Bodmer, N. Holler, S. Reynard, P. Vinciguerra, P. Schneider, and P. Juo TRAIL receptor-2 signals apoptosis through FADD and caspase-8 Nat. Cell Biol. 2 2000 241 243
100. X. Chen, H. Thakkar, F. Tyan, S. Gim, H. Robinson, and C. Lee Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer Oncogene 20 2001 6073 6083
101. G. Emons, C. Grundker, A.R. Gunthert, S. Westphalen, J. Kavanagh, and C. Verschraegen GnRH antagonists in the treatment of gynecological and breast cancers Endocr. Relat. Cancer 10 2003 291 299
102. A. Kimura, M. Ohmichi, H. Kurachi, H. Ikegami, J. Hayakawa, and K. Tasaka Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line Cancer Res. 59 1999 5133 5142
103. J.H. Kim, D.C. Park, J.W. Kim, Y.K. Choi, Y.O. Lew, and D.H. Kim Antitumor effect of GnRH agonist in epithelial ovarian cancer Gynecol. Oncol. 74 1999 170 180
104. A.R. Gunthert, C. Grundker, K. Hollmann, and G. Emons Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells Biochem. Biophys. Res. Commun. 294 2002 11 15
105. C.M. Pfarr, F. Mechta, G. Spyrou, D. Lallemand, S. Carillo, and M. Yaniv Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras Cell 76 1994 747 760
106. A. Imai, A. Takagi, S. Horibe, H. Takagi, and T. Tamaya Fas and Fas ligand system may mediate antiproliferative activity of gonadotropin-releasing hormone receptor in endometrial cancer cells Int. J. Oncol. 13 1998 97 100
107. A.R. Gunthert, C. Grundker, B. Bottcher, and G. Emons Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells Anticancer Res. 24 2004 1727 1732
108. A.R. Gunthert, C. Grundker, T. Bongertz, T. Schlott, A. Nagy, A.V. Schally, and G. Emons Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system Am. J. Obstet. Gynecol. 191 2004 1164 1172
109. C. Grundker, A.R. Gunthert, R.P. Millar, and G. Emons Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation J. Clin. Endocrinol. Metab. 87 2002 1427 1430
110. K.C. Choi, N. Auersperg, and P.C. Leung Expression and antiproliferative effect of a second form of gonadotropin-releasing hormone in normal and neoplastic ovarian surface epithelial cells J. Clin. Endocrinol. Metab. 86 2001 5075 5078
111. K.Y. Kim, K.C. Choi, S.H. Park, C.S. Chou, N. Auersperg, and P.C. Leung Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells J. Clin. Endocrinol. Metab. 89 2004 3020 3026
112. A.J. Friedman, M. Daly, M. Juneau-Norcross, M.S. Rein, C. Fine, R. Gleason, and M. Leboff A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin 'add-back' regimens for women with leiomyomata uteri J. Clin. Endocrinol. Metab. 76 1993 1439 1445
113. Y. Wang, H. Matsuo, O. Kurachi, and T. Maruo Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells Eur. J. Endocrinol. 146 2002 447 456
114. T. Mizutani, A. Sugihara, K. Nakamuro, and N. Terada Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate) J. Clin. Endocrinol. Metab. 83 1998 1253 1255
115. S.C. Huang, M.J. Tang, K.F. Hsu, Y.M. Cheng, and C.Y. Chou Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma J. Clin. Endocrinol. Metab. 87 2002 4580 4586
116. G. Bifulco, C. Miele, M. Pellicano, A. Trencia, M. Ferraioli, and F. Paturzo Molecular mechanisms involved in GnRH analogue-related apoptosis for uterine leiomyomas Mol. Hum. Reprod. 10 2004 43 48
117. E. Yang, J. Zha, J. Jockel, L.H. Boise, C.B. Thompson, and S.J. Korsmeyer Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death Cell 80 1995 285 291
118. Y. Sharoni, E. Bosin, A. Miinster, J. Levy, and A.V. Schally Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone Proc. Natl Acad. Sci. USA 86 1989 1648 1651
119. B. Vincze, I. Palyi, D. Daubner, T. Kremmer, I. Szamel, and I. Bodrogi Influence of luteinizing hormone-releasing hormone agonists on human mammary carcinoma cell lines and their xenografts J. Steroid Biochem. Mol. Biol. 38 1991 119 126
120. T. Yano, E. Korkut, J. Pinski, K. Szepeshazi, S. Milovanovic, and K. Groot Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH Breast. Cancer Res. Treat. 21 1992 35 45
121. T. Yano, J. Pinski, K. Szepeshazi, G. Halmos, S. Radulovic, K. Groot, and A.V. Schally Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and luteinizing hormone-releasing hormone antagonist SB-75 on the growth of MCF-7 MIII human breast cancer xenografts in athymic nude mice Cancer 73 1994 1229 1238
122. G. Keri, A. Balogh, B. Szoke, I. Teplan, and O. Csuka Gonadotropin-releasing hormone analogues inhibit cell proliferation and activate signal transduction pathways in MDA-MB-231 human breast cancer cell line Tumour Biol. 12 1991 61 67
123. C. Grundker, A.R. Gunthert, M. Hellriegel, and G. Emons Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells Eur. J. Endocrinol. 151 2004 619 628
124. K. Szepeshazi, A.V. Schally, A. Juhasz, A. Nagy, and T. Janaky Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivo Anticancer Drugs 3 1992 109 116
125. A. Chen, E. Kaganovsky, S. Rahimipour, N. Ben-Aroya, E. Okon, and Y. Koch Two forms of GnRH are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2 Cancer Res. 62 2002 1036 1044
126. G. Emons, and J.J. Kavanagh Hormonal interactions in ovarian cancer Hematol. Oncol. Clin. North Am. 141 1999 1 14
127. A.V. Schally, and A. Nagy Chemotherapy targeted to cancers through tumoral hormone receptors Trends Endocrinol. Metab. 15 2004 300 310
128. A.V. Schally, and A. Nagy Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors Eur. J. Endocrinol. 141 1999 1 14
129. J.M. Arencibia, A.V. Schally, G. Halmos, A. Nagy, and H. Kiaris In vitro targeting of a cytotoxic analog of luteinizing hormone-releasing hormone AN-207 to ES-2 human ovarian cancer cells as demonstrated by microsatellite analyses Anticancer Drugs 12 2001 71 78
130. L. Chatzistamou, A.V. Schally, A. Nagy, P. Armatis, K. Szepeshazi, and G. Halmos Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207 Clin. Cancer Res. 6 2000 4158 4165
131. I. Palyi, B. Vincze, S. Lovas, I. Mezo, J. Pato, and A. Kalnay Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity Proc. Natl Acad. Sci. USA 96 1999 2361 2366
132. L. Qi, T.M. Nett, M.C. Allen, X. Sha, G.S. Harrison, and B.A. Frederick Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor Cancer Res. 64 2004 2090 2095
133. E. Wurmbach, T. Yuen, B.J. Ebersole, and S.C. Sealfon Gonadotropin-releasing hormone receptor-coupled gene network organization J. Biol. Chem. 276 2001 47195 47201
134. S.S. Kakar, S.J. Winters, W. Zacharias, D.M. Miller, and S. Flynn Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis Gene 308 2003 67 77